Tirzepatide
Dual GIP and GLP-1 receptor agonist for substantial weight loss and metabolic control.
.png&w=3840&q=75)
About Tirzepatide
Tirzepatide is a groundbreaking dual-action receptor agonist targeting both GIP and GLP-1 incretin pathways. By activating both receptors, it synergistically curbs appetite, delays gastric emptying, improves insulin secretion, and recalibrates metabolic health, delivering profound and sustained reductions in body weight.
Key Benefits
Substantial Weight Loss
Promotes profound and sustained reductions in body weight (up to 22%) and body fat.
Appetite & Satiety Control
Dramatically reduces cravings, dampens food noise, and enhances post-meal fullness.
Glycemic Regulation
Optimizes glucose control, insulin sensitivity, and lipid parameters.
Cardiometabolic Health
Supports healthy blood pressure, visceral fat reduction, and cardiovascular markers.
Pricing
Starting from ₱2,500
What's Included
Every order includes full administration supplies:
- Complete set of syringe
- BAC Water for dilution
- Alcohol pads
- Detailed instructions & guidelines
- Doctor-guided plan
Dosing Guide
Helpful Tips
- Administer on the same day each week via subcutaneous route; can be taken with or without food.
- Same active ingredient in Mounjaro with 99% purity and fewer side effects than Semaglutide.
- Prioritize high-protein intake and daily hydration to preserve lean muscle mass.
- Eat smaller, frequent portions to prevent mild early gastrointestinal adjustment symptoms.